Thomas Lincoln to Prisoners
This is a "connection" page, showing publications Thomas Lincoln has written about Prisoners.
Connection Strength
1.109
-
Lincoln T, Simon-Levine D, Smith J, Donenberg GR, Springer SA, Zaller N, Altice FL, Moore K, Jordan AO, Draine J, Desabrais M. Prevalence and Predictors of Mental/Emotional Distress Among HIV+ Jail Detainees at Enrollment in an Observational Study. J Correct Health Care. 2015 Apr; 21(2):125-39.
Score: 0.419
-
Springer SA, Di Paola A, Azar MM, Barbour R, Biondi BE, Desabrais M, Lincoln T, Skiest DJ, Altice FL. Extended-Release Naltrexone Improves Viral Suppression Among Incarcerated Persons Living With HIV With Opioid Use Disorders Transitioning to the Community: Results of a Double-Blind, Placebo-Controlled Randomized Trial. J Acquir Immune Defic Syndr. 2018 05 01; 78(1):43-53.
Score: 0.130
-
Di Paola A, Lincoln T, Skiest DJ, Desabrais M, Altice FL, Springer SA. Design and methods of a double blind randomized placebo-controlled trial of extended-release naltrexone for HIV-infected, opioid dependent prisoners and jail detainees who are transitioning to the community. Contemp Clin Trials. 2014 Nov; 39(2):256-68.
Score: 0.101
-
Spaulding AC, Messina LC, Kim BI, Chung KW, Lincoln T, Teixeira P, Avery AK, Cunningham M, Stein MS, Ahuja D, Flanigan TP. Planning for success predicts virus suppressed: results of a non-controlled, observational study of factors associated with viral suppression among HIV-positive persons following jail release. AIDS Behav. 2013 Oct; 17 Suppl 2:S203-11.
Score: 0.094
-
Chitsaz E, Meyer JP, Krishnan A, Springer SA, Marcus R, Zaller N, Jordan AO, Lincoln T, Flanigan TP, Porterfield J, Altice FL. Contribution of substance use disorders on HIV treatment outcomes and antiretroviral medication adherence among HIV-infected persons entering jail. AIDS Behav. 2013 Oct; 17 Suppl 2:S118-27.
Score: 0.094
-
Draine J, Ahuja D, Altice FL, Arriola KJ, Avery AK, Beckwith CG, Booker CA, Ferguson A, Figueroa H, Lincoln T, Ouellet LJ, Porterfield J, Spaulding AC, Tinsley MJ. Strategies to enhance linkages between care for HIV/AIDS in jail and community settings. AIDS Care. 2011 Mar; 23(3):366-77.
Score: 0.079
-
Lincoln T, Tuthill RW, Roberts CA, Kennedy S, Hammett TM, Langmore-Avila E, Conklin TJ. Resumption of smoking after release from a tobacco-free correctional facility. J Correct Health Care. 2009 Jul; 15(3):190-6.
Score: 0.069
-
Gift TL, Lincoln T, Tuthill R, Whelan M, Briggs LP, Conklin T, Irwin KL. A cost-effectiveness evaluation of a jail-based chlamydia screening program for men and its impact on their partners in the community. Sex Transm Dis. 2006 Oct; 33(10 Suppl):S103-10.
Score: 0.058
-
Vagenas P, Di Paola A, Herme M, Lincoln T, Skiest DJ, Altice FL, Springer SA. An evaluation of hepatic enzyme elevations among HIV-infected released prisoners enrolled in two randomized placebo-controlled trials of extended release naltrexone. J Subst Abuse Treat. 2014 Jul; 47(1):35-40.
Score: 0.024
-
Avery AK, Ciomcia RW, Lincoln T, Desbrais M, Jordan AO, Rana AI, Machekano R. Jails as an opportunity to increase engagement in HIV care: findings from an observational cross-sectional study. AIDS Behav. 2013 Oct; 17 Suppl 2:S137-44.
Score: 0.024
-
Joesoef MR, Weinstock HS, Kent CK, Chow JM, Boudov MR, Parvez FM, Cox T, Lincoln T, Miller JL, Sternberg M. Sex and age correlates of Chlamydia prevalence in adolescents and adults entering correctional facilities, 2005: implications for screening policy. Sex Transm Dis. 2009 Feb; 36(2 Suppl):S67-71.
Score: 0.017